HOME > TOP STORIES
TOP STORIES
-
BUSINESS Kaketsuken’s Biz Transfer Talks Fall Apart, but Minister Nixes Its Continued Operations
October 20, 2016
-
BUSINESS Astellas Calls Off Biz Transfer Talks with Kaketsuken
October 19, 2016
-
REGULATORY Urgent Need for Rule on Interim NHI Price Revisions; Current System Unable to Respond in Case of Add’l Indications: MOF Budget Examiner
October 19, 2016
-
TRENDS Gilead Stays Pat on Hep C Plan, Japan Chief Says Innovation Outstrips Re-Pricing Hit
October 18, 2016
-
REGULATORY Govt Panel Member Pushes 50%-Plus Cut for Opdivo Price
October 17, 2016
-
BUSINESS Gilead Japan Trying to Dig Up Untreated Hep C Patients as Demand Ebbs
October 14, 2016
-
BUSINESS Takeda to Tighten R&D Focus, Strengthen Collaboration with Outside Parties; Main Challenge Will Be Financial
October 13, 2016
-
BUSINESS Interview: Teva Exec Says Takeda JV Can Grow Profit despite Generic Price Declines
October 12, 2016
-
BUSINESS Teva-Takeda JV Eyes Top Spot in Off-Patent Drug Market: CEO
October 11, 2016
-
ACADEMIA Osteoporosis Experts Express “Shock” at Discontinuation of Development of Odanacatib
October 7, 2016
-
REGULATORY Chuikyo OKs Application of Huge-Seller Re-Pricing to Opdivo; Payers Loath to Use Ono Sales Outlook for Calculation
October 6, 2016
-
REGULATORY Kaketsuken Faces Another Penalty over Encephalitis Vaccine Manufacturing
October 5, 2016
-
REGULATORY MHLW, PMDA Set Up “Preparatory Offices” to Plan Future Support System for Startups
October 5, 2016
-
REGULATORY Bayer Launches Recall of Hemophilia Med Kogenate over Potency Loss
October 4, 2016
-
BUSINESS Mitsubishi Tanabe Looks to Double Late-Stage Pipelines; Faster Decisions Hold Key in Curbing Costs
October 3, 2016
-
REGULATORY MHLW Says It Will Compile “Optimal Use Guidelines” for Keytruda Too
October 3, 2016
-
BUSINESS Suzuken’s Harvoni Sales Sag 70% from Peak, Wholesaler Earnings Certain to Take Hit
September 30, 2016
-
REGULATORY Drug Costs Biggest Driver of Healthcare Spending Surge: Chuikyo JMA Rep
September 29, 2016
-
BUSINESS Tokyo Startup’s Osteoarthritis Drug Hopeful on Tap for PIb Launch by Year-End
September 28, 2016
-
REGULATORY Clinical Research Bill Set to Sail through Extra Diet with Opposition Backing
September 27, 2016
ページ
In the complex landscape of the Japanese pharmaceutical market, the “status quo” is often the safest harbor. But for leaders like Kennet Brysting, former president of Gilead Japan, the status quo is the most dangerous place to stay.Innovation in Japan…
